Time is running out to access this essential CME/NCPD-approved podcast! Join renowned dermatology experts Dr. Peter A. Lio and Dr. Linda F. Stein Gold as they dive into the latest evidence and best practices for treating atopic dermatitis in children and adolescents. With new therapies rapidly changing the treatment landscape, this podcast delivers the practical insights you need to confidently diagnose, evaluate, and manage pediatric atopic dermatitis.
Don’t miss your chance to:
-Get up to speed on novel and emerging therapies, including nonsteroidal topicals, JAK inhibitors, and monoclonal antibodies
-Learn how to recognize key clinical features that inform the differential diagnosis
-Discover strategies to optimize outcomes and quality of life for your young patients
This activity is expiring soon—listen now to stay current and earn credit before it’s gone!
Click here to claim your CME/NCPD credit: bit.ly/4nGZhBG
All content for Oncology Data Advisor is the property of i3 Health and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Time is running out to access this essential CME/NCPD-approved podcast! Join renowned dermatology experts Dr. Peter A. Lio and Dr. Linda F. Stein Gold as they dive into the latest evidence and best practices for treating atopic dermatitis in children and adolescents. With new therapies rapidly changing the treatment landscape, this podcast delivers the practical insights you need to confidently diagnose, evaluate, and manage pediatric atopic dermatitis.
Don’t miss your chance to:
-Get up to speed on novel and emerging therapies, including nonsteroidal topicals, JAK inhibitors, and monoclonal antibodies
-Learn how to recognize key clinical features that inform the differential diagnosis
-Discover strategies to optimize outcomes and quality of life for your young patients
This activity is expiring soon—listen now to stay current and earn credit before it’s gone!
Click here to claim your CME/NCPD credit: bit.ly/4nGZhBG
Additional Insights in Dedifferentiated Liposarcoma With Richard F. Riedel, MD, and Candace L. Haddox, MD
Oncology Data Advisor
37 minutes 31 seconds
3 months ago
Additional Insights in Dedifferentiated Liposarcoma With Richard F. Riedel, MD, and Candace L. Haddox, MD
As research in dedifferentiated liposarcoma (DDLPS) continues to advance, the importance of multidisciplinary collaboration and access to innovative therapies remains at the forefront of patient care. Recently, Dr. Richard Riedel of Duke Cancer Institute and Dr. Candace Haddox of Dana-Farber Cancer Institute co-chaired i3 Health’s DDLPS Task Force activity, which brought together a panel of experts to address the complexities of this rare and challenging sarcoma subtype. With new clinical trials underway and a growing understanding of the disease’s molecular landscape, Dr. Riedel and Dr. Haddox sat down to highlight promising research directions and insights in honor of Sarcoma Awareness Month in July.
After listening to the interview, stay tuned to hear the full accredited podcast with Dr. Riedel and Dr. Haddox, and click the link below to claim free CME/AAPA credit.
Click the links below for the Task Force activity!
- Accredited CME/AAPA Podcast: i3health.com/course-information/podcast-ddlps
- Position Statement Published in Cancer Treatment Reviews: www.cancertreatmentreviews.com/article/S…/fulltext
- Live Task Force Recording: youtu.be/Otr5_tiFQ68
Oncology Data Advisor
Time is running out to access this essential CME/NCPD-approved podcast! Join renowned dermatology experts Dr. Peter A. Lio and Dr. Linda F. Stein Gold as they dive into the latest evidence and best practices for treating atopic dermatitis in children and adolescents. With new therapies rapidly changing the treatment landscape, this podcast delivers the practical insights you need to confidently diagnose, evaluate, and manage pediatric atopic dermatitis.
Don’t miss your chance to:
-Get up to speed on novel and emerging therapies, including nonsteroidal topicals, JAK inhibitors, and monoclonal antibodies
-Learn how to recognize key clinical features that inform the differential diagnosis
-Discover strategies to optimize outcomes and quality of life for your young patients
This activity is expiring soon—listen now to stay current and earn credit before it’s gone!
Click here to claim your CME/NCPD credit: bit.ly/4nGZhBG
